MedTrace Logo

Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy

NCT05191719 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2023-10-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate neurotomy as an alternative treatment to Botox injections for severe synkinesis following peripheral facial palsy

Conditions

  • Facial Paralysis
  • Facial Palsy
  • Peripheral Facial Palsy
  • Peripheral Facial Paralysis
  • Bell Palsy
  • Synkinesis

Interventions

PROCEDURE

Botox injection

Comparator, current gold standard

PROCEDURE

Neurotomy

Surgical procedure

Sponsors & Collaborators

  • Rebecka Ohm

    lead OTHER

Principal Investigators

  • Birgit Stark, MD, PhD · Karolinska Institute/Karolinska University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05191719 on ClinicalTrials.gov